Categories
Change Password!
Reset Password!
Low-dose epidural hydromorphone delivers sustained postpartum analgesia and improves patient-reported recovery outcomes after childbirth.
A randomized controlled trial involving 460 women has found that a single low-dose epidural bolus of hydromorphone remarkably optimizes pain relief in the first 48 hours after vaginal delivery, while boosting maternal satisfaction and functional recovery.
In the study, term parturients who had vaginal births were randomly allocated to get either epidural hydromorphone (n = 230) or an equal volume of normal saline (n = 230). Postpartum pain outcomes were assessed over the first 2 days following delivery. Women in the hydromorphone group reported substantially lower pain scores within 48 hours postpartum.
More than three-quarters of women receiving hydromorphone attained clinically acceptable pain control (pain score ≤ 3), compared with fewer than one-third in the saline group. The need for additional analgesics was markedly reduced in the hydromorphone group. Time to first rescue analgesia was also quite longer among women who received hydromorphone (Table 1).
Adverse effects—including nausea, vomiting, dizziness, pruritus, and urinary retention—occurred more frequently in the hydromorphone group. However, sleep disturbances were markedly less common when compared with controls (5.43% vs 30.18%). Importantly, no differences were noted between groups in postpartum inflammatory markers. Beyond pain relief, epidural hydromorphone was linked with higher maternal satisfaction and improved postpartum autonomy, suggesting benefits that extend beyond analgesia alone.
Overall, the findings indicate that low-dose epidural hydromorphone yields effective and sustained postpartum pain control after vaginal delivery. While the higher rate of mild adverse effects warrants careful consideration, the favorable balance between analgesic potency, functional recovery, and maternal satisfaction supports its potential role as a viable option for acute postpartum pain management.
Scientific Reports
Single epidural bolus hydromorphone for acute postpartum pain after vaginal delivery: a randomized clinical trial
Yixing Lu et al.
Comments (0)